Shingles Vaccine
A vaccine used to prevent shingles; research has suggested a possible association with a reduced risk of Alzheimer's disease, though the mechanism remains unclear.
Timeline (last 90 days)
There is an observational association between shingles vaccination and a reduced risk of Alzheimer's disease, but the mechanism is unclear and it is not yet sufficient as a basis for clinical recommendations.
A natural experiment based on an age cutoff found that people eligible for the shingles vaccine appeared to have a lower chance of developing Alzheimer's disease.
One hypothesis holds that VZV reactivation may indirectly affect the central nervous system through neuroinflammation or immune activation, and that the vaccine may provide protection by reducing the frequency of viral reactivation or modulating innate immunity.
All of the above hypotheses about the protective mechanism of the shingles vaccine lack direct human causal evidence.
All Facts (4)
There is an observational association between shingles vaccination and a reduced risk of Alzheimer's disease, but the mechanism is unclear and it is not yet sufficient as a basis for clinical recommendations.
50%UnverifiedA natural experiment based on an age cutoff found that people eligible for the shingles vaccine appeared to have a lower chance of developing Alzheimer's disease.
50%UnverifiedAll of the above hypotheses about the protective mechanism of the shingles vaccine lack direct human causal evidence.
50%UnverifiedOne hypothesis holds that VZV reactivation may indirectly affect the central nervous system through neuroinflammation or immune activation, and that the vaccine may provide protection by reducing the frequency of viral reactivation or modulating innate immunity.
50%